Picture of Medrx logo

4586 — Medrx News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Medrx commences additional trial of phase I clinical trial for MRX-4TZT

Sept 1 (Reuters) - Medrx Co Ltd  4586.T  
    
    * Says it commences additional trial of phase I clinical 
trial for spastic paralysis treatment plasters(MRX-4TZT) in U.S. 
 
    Source text in Japanese: https://goo.gl/kJWhKv 
    Further company coverage: 4586.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))

Recent news on Medrx

See all news